Spectrum Spine provides FDA-cleared spinal implant systems designed to enhance bone growth and reduce the need for bone grafts in spine surgery. Their anterior cervical cage system features BioBraille surface technology to promote osseointegration, simplifying procedures and improving patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Spine surgery often requires bone grafting, which can be costly and carry risks. Current spinal implant technologies have not significantly advanced to address this need for improved bone integration and reduced reliance on graft materials.
Solution
Spectrum Spine offers FDA-cleared spinal implant systems designed to enhance bone growth and potentially eliminate the need for bone grafts. Their anterior cervical cage system incorporates an innovative BioBraille surface technology, engineered to promote osseointegration. This approach aims to simplify surgical procedures and improve patient outcomes by providing a more integrated and biologically conducive implant solution. The company is focused on developing advanced technologies that address critical needs in spine surgery.
Target Audience
The primary customers are orthopedic and neurosurgeons specializing in spine surgery who require advanced interbody fusion devices.
Features
- FDA-cleared anterior cervical cage system for anterior cervical interbody fusion.
- BioBraille surface technology designed to promote bone growth and osseointegration.
- Titanium alloy (Ti-6Al-4V ELI per ASTM F136) construction for implant components.
- Large graft window within the cage to accommodate bone graft material.
- Available in multiple footprints, heights, and lordotic angles to suit patient anatomy.
- Offered with both smooth and rough surface finishes.
- Compatible with autograft bone, allograft bone, demineralized allograft with bone marrow aspirate, or combinations thereof.
- Requires supplemental fixation cleared by the FDA for cervical spine use.